11/11/2025
UHMBT R & D are beyond pleased to share that we are the first site in the UK to consent and recruit a participant to the AIRTIVITY Research Trial. This trial is investigating whether a certain treatment improves the lives of people with bronchiectasis 🫁
Research Nurse Kerry explains why studies like AIRTIVITY are so important:
“Bronchiectasis is a disease with limited effective treatments, so to be part of developing a potential new treatment is very exciting for our patients. It’s also very pleasing to be able to offer patients in north Lancs and South Cumbria the chance to be part of research when historically patients have had to travel further afield.”
he goes on to say that AIRTIVITY “is also the first commercial respiratory trial we have conducted at both FGH and RLI, which is a big milestone for the trust. This could not have been achieved without having our Respiratory Research Nurse Rose based at FGH supported by the rest of the delivery team.”
“I am very proud of all our respiratory research team at UHMB. This achievement could not have happened without each and every one of them.”
Find out more here https://buff.ly/H4V3Ila